ArticleExperimental neurology2026
Proteomics reveal PTEN as a critical mediator of sustained mitochondrial dysfunction during chronic spinal cord injury.
Article in Experimental neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
Activity of the phosphatase and tensin homologue protein (PTEN) remains elevated in neurons chronically after spinal cord injury (SCI) and suppresses tissue repair. However, PTEN may also disrupt other neuronal functions not directly related to regeneration. To better understand the role of PTEN on neuronal functions in chronic SCI, neuronal-specific PTEN-KO was induced using spinal injections of retrogradely-transported AAVs (AAVrg) immediately after contusion SCI in mice. Spinal cords were harvested at 6 weeks post-injury and untargeted total proteomics was performed. Bioinformatics analyses revealed a downregulation of mitochondrial-associated proteins in chronic SCI that was reversed after PTEN-KO. We replicated the experimental conditions to validate the effects of chronic SCI ± PTEN-KO on mitochondrial functions using ex vivo respiratory testing on whole-spinal cord mitochondrial isolates. Mitochondrial respiratory capacity was reduced in chronic SCI and was restored after PTEN-KO. Next, we evaluated the extent to which chronic SCI specifically affects neuronal mitochondria and whether PGC1α upregulation can restore respiratory capacity. We designed an AAVrg vector to enable a magnetic bead pulldown approach to isolate neuron-specific mitochondria with, or without, concurrent PGC1α upregulation. AAVrg vectors were delivered into the spinal cord at 15-weeks post-injury, and neuron-specific mitochondria were isolated 6-weeks later. Neuronal mitochondria present a ∼ 50% loss of respiratory capacity in chronic SCI that was restored with PGC1α upregulation. Collectively, we demonstrate that mitochondrial respiratory abilities are significantly repressed chronically after SCI, that PTEN is a major contributor to sustained mitochondrial dysfunction, and that PGC1α upregulation can restore mitochondrial bioenergetic abilities during chronic SCI. SIGNIFICANCE STATEMENT: Chronic spinal cord injury (SCI) is hallmarked by sustained motor and sensory dysfunction with little potential for repair. The chronic SCI environment limits the excitability of spared neural circuits and significantly reduces the regenerative potential of exogenously applied therapeutics. Through a series of experiments, we have derived a novel and significant observation that neuronal mitochondria exhibit a ∼ 50% loss of respiratory abilities chronically after SCI in mice. Moreover, by knocking out PTEN, a protein known to be chronically hyperactive after SCI, we demonstrate the ability to restore mitochondrial respiratory abilities. Our discoveries highlight a novel and vital pathological mechanism that is sustained chronically after SCI that is mediated by neuronal PTEN activity.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.